Journal of Neuroinflammation,
Journal Year:
2020,
Volume and Issue:
17(1)
Published: Oct. 13, 2020
Alzheimer's
disease
(AD)
is
the
most
common
form
of
dementia,
characterized
by
progressive
degeneration
and
loss
neurons
in
specific
regions
central
nervous
system.
Chronic
activation
immune
cells
resident
brain,
peripheral
cell
trafficking
across
blood-brain
barrier,
release
inflammatory
neurotoxic
factors,
appear
critical
contributors
neuroinflammatory
response
that
drives
progression
neurodegenerative
processes
AD.
As
neuro-immune
network
impaired
course
AD,
this
review
aimed
to
point
out
essential
supportive
role
innate
adaptive
either
normal
brain
as
well
recovery
from
injury.
Since
a
fine-tuning
appears
crucial
ensure
proper
system
functioning,
we
focused
on
TNF
superfamily
member,
TNF-related
apoptosis-inducing
ligand
(TRAIL),
which
modulates
both
pathogenesis
several
immunological
disorders
and,
particular,
AD-related
neuroinflammation.
We
here
summarized
mounting
evidence
potential
involvement
TRAIL
signaling
AD
pathogenesis,
with
aim
provide
clearer
insights
about
novel
therapeutic
approaches
European Journal of Immunology,
Journal Year:
2019,
Volume and Issue:
49(10), P. 1457 - 1973
Published: Oct. 1, 2019
These
guidelines
are
a
consensus
work
of
considerable
number
members
the
immunology
and
flow
cytometry
community.
They
provide
theory
key
practical
aspects
enabling
immunologists
to
avoid
common
errors
that
often
undermine
immunological
data.
Notably,
there
comprehensive
sections
all
major
immune
cell
types
with
helpful
Tables
detailing
phenotypes
in
murine
human
cells.
The
latest
techniques
applications
also
described,
featuring
examples
data
can
be
generated
and,
importantly,
how
analysed.
Furthermore,
tips,
tricks
pitfalls
avoid,
written
peer-reviewed
by
leading
experts
field,
making
this
an
essential
research
companion.
European Journal of Neuroscience,
Journal Year:
2020,
Volume and Issue:
53(1), P. 151 - 171
Published: March 9, 2020
Abstract
Some
recent
clinical
and
preclinical
evidence
suggests
that
neuroinflammation
is
a
key
factor
interacts
with
the
three
neurobiological
correlates
of
major
depressive
disorder:
depletion
brain
serotonin,
dysregulation
hypothalamus–pituitary–adrenal
(HPA)
axis
alteration
continuous
production
adult‐generated
neurons
in
dentate
gyrus
hippocampus.
This
review
discusses
main
players
immunity
as
well
how
inflammation
above
mechanisms.
It
reported
kynurenine
(KYN)
pathway
favour
its
excitotoxic
component
HPA
have
common
effect
increasing
extracellular
glutamate
levels
neurotransmission,
which
can
impact
hippocampal
neurogenesis.
pathophysiological
cascade
appears
to
be
triggered
or
sustained
reinforced
by
any
chronic
inflammatory
condition
involving
increased
circulating
markers
are
able
cross
blood–brain
barrier
activate
microglia;
it
also
consequence
primary
neuroinflammation,
such
neurodegenerative
disorders
early
manifestations
frequently
symptoms.
Further
data
indicate
microglial
activation
may
result
from
direct
stress
on
vascular
function.
The
intricated
dynamic
crosstalk
between
other
relevant
depression
add
therapeutic
target
for
future
strategies
disorder.
European Journal of Immunology,
Journal Year:
2021,
Volume and Issue:
51(12), P. 2708 - 3145
Published: Dec. 1, 2021
Abstract
The
third
edition
of
Flow
Cytometry
Guidelines
provides
the
key
aspects
to
consider
when
performing
flow
cytometry
experiments
and
includes
comprehensive
sections
describing
phenotypes
functional
assays
all
major
human
murine
immune
cell
subsets.
Notably,
contain
helpful
tables
highlighting
differences
between
cells.
Another
useful
feature
this
is
analysis
clinical
samples
with
examples
applications
in
context
autoimmune
diseases,
cancers
as
well
acute
chronic
infectious
diseases.
Furthermore,
there
are
detailing
tips,
tricks
pitfalls
avoid.
All
written
peer‐reviewed
by
leading
experts
immunologists,
making
an
essential
state‐of‐the‐art
handbook
for
basic
researchers.
Glia,
Journal Year:
2019,
Volume and Issue:
67(12), P. 2221 - 2247
Published: Aug. 19, 2019
Abstract
Astrocytes
are
key
cellular
partners
for
neurons
in
the
central
nervous
system.
react
to
virtually
all
types
of
pathological
alterations
brain
homeostasis
by
significant
morphological
and
molecular
changes.
This
response
was
classically
viewed
as
stereotypical
is
called
astrogliosis
or
astrocyte
reactivity.
It
long
considered
a
nonspecific,
secondary
reaction
conditions,
offering
no
clues
on
disease‐causing
mechanisms
with
little
therapeutic
value.
However,
many
studies
over
last
30
years
have
underlined
crucial
active
roles
played
astrocytes
physiology,
ranging
from
metabolic
support,
synapse
maturation,
pruning
fine
regulation
synaptic
transmission.
prompted
researchers
explore
how
these
new
functions
were
changed
disease,
they
reported
them
(sometimes
beneficial,
mostly
deleterious).
More
recently,
cell‐specific
transcriptomics
revealed
that
undergo
massive
changes
gene
expression
when
become
reactive.
observation
further
stressed
reactive
may
be
very
different
normal,
nonreactive
could
influence
disease
outcomes.
To
make
picture
even
more
complex,
both
normal
shown
molecularly
functionally
heterogeneous.
Very
known
about
specific
each
subtype
play
contexts.
In
this
review,
we
interrogated
field
identify
discuss
points
consensus
controversies
astrocytes,
starting
their
name.
We
then
present
emerging
knowledge
cells
future
challenges
field.
Nature Communications,
Journal Year:
2020,
Volume and Issue:
11(1)
Published: July 27, 2020
Abstract
Reactive
astrocytes
have
been
implicated
in
the
pathogenesis
of
neurodegenerative
diseases,
including
a
non-cell
autonomous
effect
on
motor
neuron
survival
ALS.
We
previously
defined
mechanism
by
which
microglia
release
three
factors,
IL-1α,
TNFα,
and
C1q,
to
induce
neurotoxic
astrocytes.
Here
we
report
that
knocking
out
these
factors
markedly
extends
SOD1
G93A
ALS
mouse
model,
providing
evidence
for
gliosis
as
potential
therapeutic
target.